SUVRETTA CAPITAL MANAGEMENT, LLC - 26 Sep 2024 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
Director, 10%+ Owner
Signature
Suvretta Capital Management, LLC; By: /s/Andrew Nathanson , General Counsel & Chief Compliance Officer
Issuer symbol
BNTC
Transactions as of
26 Sep 2024
Net transactions value
+$21,135,373
Form type
4
Filing time
30 Sep 2024, 17:17:45 UTC
Previous filing
02 May 2024
Next filing
21 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNTC Common stock, par value $0.0001 per share Exercise of in-the-money or at-the-money derivative security $1,135,237 +588,236 +40% $1.93 2,058,415 26 Sep 2024 See footnotes F1, F2
transaction BNTC Common stock, par value $0.0001 per share Exercise of in-the-money or at-the-money derivative security $17,775,300 +4,605,000 +224% $3.86 6,663,415 26 Sep 2024 See footnotes F1, F3
transaction BNTC Common stock, par value $0.0001 per share Exercise of in-the-money or at-the-money derivative security $122 +1,219,970 +18% $0.000100 7,883,385 26 Sep 2024 See footnotes F1, F4
transaction BNTC Common stock, par value $0.0001 per share Exercise of in-the-money or at-the-money derivative security $2,224,699 +576,347 +261% $3.86 797,458 26 Sep 2024 See footnotes F1, F5
transaction BNTC Common stock, par value $0.0001 per share Exercise of in-the-money or at-the-money derivative security $14.82 +148,210 +19% $0.000100 945,668 26 Sep 2024 See footnotes F1, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNTC Series 2 Common Warrants Exercise of in-the-money or at-the-money derivative security $0 -10,000,000 -100% $0.000000 0 26 Sep 2024 Common Stock 588,236 $1.93 See footnotes F1, F2
transaction BNTC Common Warrants Exercise of in-the-money or at-the-money derivative security $0 -4,605,000 -100% $0.000000 0 26 Sep 2024 Common Stock 4,605,000 $3.86 See footnotes F1, F3
transaction BNTC Pre-Funded Warrants Exercise of in-the-money or at-the-money derivative security $0 -1,219,970 -26% $0.000000 3,385,030 26 Sep 2024 Common Stock 4,605,000 $0.000100 See footnotes F1, F4, F7
transaction BNTC Common Warrants Exercise of in-the-money or at-the-money derivative security $0 -576,347 -100% $0.000000 0 26 Sep 2024 Common Stock 576,347 $3.86 See footnotes F1, F5
transaction BNTC Pre-Funded Warrants Exercise of in-the-money or at-the-money derivative security $0 -148,210 -26% $0.000000 428,137 26 Sep 2024 Common Stock 576,347 $0.000100 See footnotes F1, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Notes are included on Exhibit 99.1.
F2 Notes are included on Exhibit 99.1.
F3 Notes are included on Exhibit 99.1.
F4 Notes are included on Exhibit 99.1.
F5 Notes are included on Exhibit 99.1.
F6 Notes are included on Exhibit 99.1.
F7 Notes are included on Exhibit 99.1.

Remarks:

Exhibit List: Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filer Information Exhibit 99.3 - Joint Filers' Signature